We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$128B
AUM Growth
-$140B
Cap. Flow
-$131B
Cap. Flow %
-102.41%
Top 10 Hldgs %
21.91%
Holding
5,876
New
1,592
Increased
605
Reduced
2,310
Closed
907

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.85B
2
MSFT icon
Microsoft
MSFT
+$1.75B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.22B
4
AMZN icon
Amazon
AMZN
+$1.04B
5
IYR icon
iShares US Real Estate ETF
IYR
+$924M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 14.44%
3 Healthcare 10.25%
4 Consumer Discretionary 9.7%
5 Communication Services 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTT
4301
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$18K ﹤0.01%
+12,040
New +$24.4K
GBL
4302
DELISTED
GAMCO Investors, Inc.
GBL
$18K ﹤0.01%
826
-5,344
-87% -$119K
MBII
4303
DELISTED
Marrone Bio Innovations, Inc.
MBII
$18K ﹤0.01%
16,439
-147,032
-90% -$111K
ARDX icon
4304
Ardelyx
ARDX
$1.25B
$17K ﹤0.01%
15,686
-101,601
-87% -$90.8K
BTI icon
4305
British American Tobacco
BTI
$133B
$17K ﹤0.01%
390
-14,797
-97% -$631K
FBIO icon
4306
Fortress Biotech
FBIO
$109M
$17K ﹤0.01%
794
-5,229
-87% -$143K
FOUR icon
4307
Shift4
FOUR
$4.26B
$17K ﹤0.01%
+284
New +$15K
HROW icon
4308
Harrow
HROW
$1.45B
$17K ﹤0.01%
2,467
REFI
4309
Chicago Atlantic Real Estate Finance
REFI
$249M
$17K ﹤0.01%
+972
New +$18K
SKM icon
4310
SK Telecom
SKM
$12.2B
$17K ﹤0.01%
678
+677
+67,700% +$17.5K
VRCA icon
4311
Verrica Pharmaceuticals
VRCA
$90.4M
$17K ﹤0.01%
213
-1,377
-87% -$113K
WMG icon
4312
Warner Music
WMG
$14.4B
$17K ﹤0.01%
+442
New +$16.7K
FFAI
4313
Faraday Future Intelligent Electric
FFAI
$13.7M
0
HLTH
4314
DELISTED
Cue Health Inc. Common Stock
HLTH
$17K ﹤0.01%
+2,455
New +$22.2K
ALPN
4315
DELISTED
Alpine Immune Sciences Inc
ALPN
$17K ﹤0.01%
1,886
-12,212
-87% -$106K
USX
4316
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$17K ﹤0.01%
4,368
-28,286
-87% -$127K
EVLO
4317
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$17K ﹤0.01%
247
-1,596
-87% -$133K
CDAK
4318
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$17K ﹤0.01%
+2,585
New +$16.2K
ALGS icon
4319
Aligos Therapeutics
ALGS
$26.7M
$16K ﹤0.01%
+318
New +$25.5K
ATER icon
4320
Aterian
ATER
$4.23M
$16K ﹤0.01%
+514
New +$18.8K
BKKT icon
4321
PUT
Bakkt Inc
BKKT
$333M
$16K ﹤0.01%
+104
New +$14.8K
CRDF icon
4322
Cardiff Oncology
CRDF
$66.2M
$16K ﹤0.01%
+6,188
New +$21.9K
HQI icon
4323
HireQuest
HQI
$188M
$16K ﹤0.01%
+826
New +$15.2K
IBIO icon
4324
iBio
IBIO
$69.1M
$16K ﹤0.01%
70
-455
-87% -$95.2K
ICAD
4325
DELISTED
iCAD Inc
ICAD
$16K ﹤0.01%
3,556
-23,016
-87% -$116K

Similar funds

Barclays's Q1 2022 Portfolio in Review

As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Barclays opened a new position in Stellantis worth $331M.

  • Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
  • Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
  • Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
  • Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
  • Barclays opened 1,592 new positions and closed 907 in Q1 2022.
  • Barclays's portfolio value fell 52% quarter-over-quarter to $128B.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.